(CG) Carlyle - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14316J1088

Private Equity, Real Assets, Credit, Infrastructure, Venture

Dividends

Dividend Yield 2.42%
Yield on Cost 5y 5.26%
Yield CAGR 5y 8.78%
Payout Consistency 91.2%
Payout Ratio 35.6%
Risk via 5d forecast
Volatility 36.7%
Value at Risk 5%th 59.4%
Relative Tail Risk -1.62%
Reward TTM
Sharpe Ratio 0.38
Alpha -11.77
CAGR/Max DD 0.81
Character TTM
Hurst Exponent 0.543
Beta 1.717
Beta Downside 2.119
Drawdowns 3y
Max DD 38.53%
Mean DD 11.49%
Median DD 10.60%

Description: CG Carlyle October 16, 2025

The Carlyle Group Inc. (NASDAQ: CG) is a global alternative-asset manager that deploys capital through both direct investments and fund-of-fund structures, targeting a broad spectrum of strategies from leveraged buyouts and distressed credit to venture-stage growth and structured finance.

Its operations are organized into four core segments-Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions-allowing it to invest across more than 30 industries, including industrial manufacturing, aerospace & defense, fintech, renewable energy, and consumer retail. This diversification lets Carlyle capture value from macro-driven trends such as infrastructure spending, ESG-focused capital flows, and the ongoing digital transformation of traditional sectors.

As of the most recent filing, Carlyle reported approximately $426 billion in assets under management, generating $5.2 billion of revenue in 2023 with a net income margin of roughly 12 %, while fee-related earnings grew 8 % year-over-year, reflecting strong fundraising momentum and higher fee-related earnings from its expanding private-equity and real-asset platforms. For investors seeking deeper quantitative analysis, a look-up on ValueRay can provide granular, up-to-date performance metrics and scenario modeling tools.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (661.5m TTM) > 0 and > 6% of Revenue (6% = 221.5m TTM)
FCFTA -0.09 (>2.0%) and ΔFCFTA -8.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -56.75% (prev 83.71%; Δ -140.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.09 (>3.0%) and CFO -2.43b <= Net Income 661.5m (YES >=105%, WARN >=100%)
Net Debt (9.40b) to EBITDA (1.15b) ratio: 8.16 <= 3.0 (WARN <= 3.5)
Current Ratio 0.67 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (376.5m) change vs 12m ago 3.02% (target <= -2.0% for YES)
Gross Margin 80.96% (prev 76.77%; Δ 4.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 14.85% (prev 12.98%; Δ 1.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.37 (EBITDA TTM 1.15b / Interest Expense TTM 702.9m) >= 6 (WARN >= 3)

Altman Z'' 0.03

(A) -0.08 = (Total Current Assets 4.26b - Total Current Liabilities 6.35b) / Total Assets 27.06b
(B) 0.06 = Retained Earnings (Balance) 1.62b / Total Assets 27.06b
(C) 0.04 = EBIT TTM 962.8m / Avg Total Assets 24.86b
(D) 0.08 = Book Value of Equity 1.62b / Total Liabilities 20.21b
Total Rating: 0.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 32.73

1. Piotroski 3.0pt
2. FCF Yield -8.46%
3. FCF Margin -68.19%
4. Debt/Equity 2.25
5. Debt/Ebitda 8.16
6. ROIC - WACC (= -0.54)%
7. RoE 11.67%
8. Rev. Trend -3.01%
9. EPS Trend -30.00%

What is the price of CG shares?

As of December 16, 2025, the stock is trading at USD 57.80 with a total of 2,800,315 shares traded.
Over the past week, the price has changed by +2.81%, over one month by +12.50%, over three months by -12.89% and over the past year by +12.48%.

Is CG a buy, sell or hold?

Carlyle has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold CG.
  • Strong Buy: 4
  • Buy: 3
  • Hold: 10
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the CG price?

Issuer Target Up/Down from current
Wallstreet Target Price 65 12.5%
Analysts Target Price 65 12.5%
ValueRay Target Price 62.8 8.7%

CG Fundamental Data Overview December 10, 2025

Market Cap USD = 20.34b (20.34b USD * 1.0 USD.USD)
P/E Trailing = 31.5843
P/E Forward = 12.4378
P/S = 6.3383
P/B = 3.6627
P/EG = 0.9788
Beta = 2.055
Revenue TTM = 3.69b USD
EBIT TTM = 962.8m USD
EBITDA TTM = 1.15b USD
Long Term Debt = 12.54b USD (estimated: total debt 12.66b - short term 118.7m)
Short Term Debt = 118.7m USD (from shortTermDebt, last quarter)
Debt = 12.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.40b USD (from netDebt column, last quarter)
Enterprise Value = 29.74b USD (20.34b + Debt 12.66b - CCE 3.26b)
Interest Coverage Ratio = 1.37 (Ebit TTM 962.8m / Interest Expense TTM 702.9m)
FCF Yield = -8.46% (FCF TTM -2.52b / Enterprise Value 29.74b)
FCF Margin = -68.19% (FCF TTM -2.52b / Revenue TTM 3.69b)
Net Margin = 17.92% (Net Income TTM 661.5m / Revenue TTM 3.69b)
Gross Margin = 80.96% ((Revenue TTM 3.69b - Cost of Revenue TTM 702.9m) / Revenue TTM)
Gross Margin QoQ = 73.47% (prev 83.10%)
Tobins Q-Ratio = 1.10 (Enterprise Value 29.74b / Total Assets 27.06b)
Interest Expense / Debt = 1.64% (Interest Expense 207.1m / Debt 12.66b)
Taxrate = -31.12% (negative due to tax credits) (-26.7m / 85.8m)
NOPAT = 1.26b (EBIT 962.8m * (1 - -31.12%)) [negative tax rate / tax credits]
Current Ratio = 0.67 (Total Current Assets 4.26b / Total Current Liabilities 6.35b)
Debt / Equity = 2.25 (Debt 12.66b / totalStockholderEquity, last quarter 5.62b)
Debt / EBITDA = 8.16 (Net Debt 9.40b / EBITDA 1.15b)
Debt / FCF = -3.74 (negative FCF - burning cash) (Net Debt 9.40b / FCF TTM -2.52b)
Total Stockholder Equity = 5.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 661.5m / Total Assets 27.06b)
RoE = 11.67% (Net Income TTM 661.5m / Total Stockholder Equity 5.67b)
RoCE = 5.29% (EBIT 962.8m / Capital Employed (Equity 5.67b + L.T.Debt 12.54b))
RoIC = 7.89% (NOPAT 1.26b / Invested Capital 16.01b)
WACC = 8.43% (E(20.34b)/V(33.00b) * Re(12.34%) + D(12.66b)/V(33.00b) * Rd(1.64%) * (1-Tc(-0.31)))
Discount Rate = 12.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.15%
Fair Price DCF = unknown (Cash Flow -2.52b)
EPS Correlation: -30.00 | EPS CAGR: -17.89% | SUE: -0.73 | # QB: 0
Revenue Correlation: -3.01 | Revenue CAGR: -14.21% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=-0.040 | Revisions Net=-2 | Analysts=8
EPS next Year (2026-12-31): EPS=4.78 | Chg30d=-0.091 | Revisions Net=-5 | Growth EPS=+18.4% | Growth Revenue=+23.4%

Additional Sources for CG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle